search results for 
Logo

Fresenius SE & Co. KGaA
Consolidated statement of cash flows

January 1 to December 31, € in millionsNote20132012
Operating activities
Net income1,7381,732
Adjustments to reconcile net income to cash and cash equivalents provided by operating activities
Depreciation and amortization17, 18, 19843776
Gain on sale of investments and divestitures2-550
Change in deferred taxes122-22
Gain / loss on sale of fixed assets-1411
Changes in assets and liabilities, net of amounts from businesses acquired or disposed of
Trade accounts receivable, net1518-193
Inventories16-268-37
Other current and non-current assets1778-68
Accounts receivable from / payable to related parties-8-23
Trade accounts payable, accrued expenses and other short-term and long-term liabilities48284
Accruals for income taxes-62-22
Net cash provided by operating activities2,3202,438
Investing activities
Purchase of property, plant and equipment-1,071-970
Proceeds from sales of property, plant and equipment2418
Acquisitions and investments, net of cash acquired and net purchases of intangible assets2, 31
-2,703-2,500
Proceeds from sale of investments and divestitures147201
Net cash used in investing activities-3,603-3,251
Financing activities
Proceeds from short-term loans221,088161
Repayments of short-term loans22-319-168
Proceeds from short-term loans from related parties--
Repayments of short-term loans from related parties--
Proceeds from long-term debt and capital lease obligations223,8102,937
Repayments of long-term debt and capital lease obligations22-2,042-3,881
Proceeds from the issuance of bearer ordinary shares2601,014
Payments of additional costs of the capital increase260-16
Proceeds from the issuance of Senior Notes235001,755
Repayments of liabilities from Senior Notes23-1,1500
Payments for the share buy-back program of Fresenius Medical Care26-3850
Changes of accounts receivable securitization program22142-290
Proceeds from the exercise of stock options33152140
Dividends paid-491-446
Change in noncontrolling interest25-2-131
Exchange rate effect due to corporate financing2-
Net cash provided by financing activities1,3051,075
Effect of exchange rate changes on cash and cash equivalents-43-12
Net increase / decrease in cash and cash equivalents-21250
Cash and cash equivalents at the beginning of the reporting period14885635
Cash and cash equivalents at the end of the reporting period14864885

January 1 to December 31, € in millionsNote20132012
Operating activities
Net income1,7381,732
Adjustments to reconcile net income to cash and cash equivalents provided by operating activities
Depreciation and amortization17, 18, 19843776
Gain on sale of investments and divestitures2-550
Change in deferred taxes122-22
Gain / loss on sale of fixed assets-1411
Changes in assets and liabilities, net of amounts from businesses acquired or disposed of
Trade accounts receivable, net1518-193
Inventories16-268-37
Other current and non-current assets1778-68
Accounts receivable from / payable to related parties-8-23
Trade accounts payable, accrued expenses and other short-term and long-term liabilities48284
Accruals for income taxes-62-22
Net cash provided by operating activities2,3202,438
Investing activities
Purchase of property, plant and equipment-1,071-970
Proceeds from sales of property, plant and equipment2418
Acquisitions and investments, net of cash acquired and net purchases of intangible assets2, 31
-2,703-2,500
Proceeds from sale of investments and divestitures147201
Net cash used in investing activities-3,603-3,251
Financing activities
Proceeds from short-term loans221,088161
Repayments of short-term loans22-319-168
Proceeds from short-term loans from related parties--
Repayments of short-term loans from related parties--
Proceeds from long-term debt and capital lease obligations223,8102,937
Repayments of long-term debt and capital lease obligations22-2,042-3,881
Proceeds from the issuance of bearer ordinary shares2601,014
Payments of additional costs of the capital increase260-16
Proceeds from the issuance of Senior Notes235001,755
Repayments of liabilities from Senior Notes23-1,1500
Payments for the share buy-back program of Fresenius Medical Care26-3850
Changes of accounts receivable securitization program22142-290
Proceeds from the exercise of stock options33152140
Dividends paid-491-446
Change in noncontrolling interest25-2-131
Exchange rate effect due to corporate financing2-
Net cash provided by financing activities1,3051,075
Effect of exchange rate changes on cash and cash equivalents-43-12
Net increase / decrease in cash and cash equivalents-21250
Cash and cash equivalents at the beginning of the reporting period14885635
Cash and cash equivalents at the end of the reporting period14864885

The following notes are an integral part of the consolidated financial statements.

QUICKFINDER

History

Tools